BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update

Go back to BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q2 EPS by 2c

August 13, 2015 8:49 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More